| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENOV | Common stock, par value $0.001 | Award | $0 | +47.4K | +17.55% | $0.00 | 317K | Feb 17, 2025 | Direct | F1 |
| transaction | ENOV | Common stock, par value $0.001 | Tax liability | -$1.06M | -24.1K | -7.59% | $43.89 | 293K | Feb 17, 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2022. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2023 Fiscal Year-End" table on page 44 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 5, 2024. |
| F2 | Represents shares that have been withheld by the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of PRSUs and time-based restricted stock units and does not represent a sale by the reporting person. |